Comments
Loading...
EyePoint Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:EYPT | Benzinga
EyePoint Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.550
Quarterly Revenue Estimate
$8.09M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$43.27M
Analyze the earnings history of EyePoint Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals | -$0.55 | -$0.55 | — | — | $11.68M | $8.09M | — | — | 05/07/2025 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$0.33 | -$0.48 | -$0.64 | -33.33% | $14.03M | $11.02M | $11.59M | 5.15% | 03/05/2025 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$0.33 | -$0.55 | -$0.54 | 1.82% | $15.20M | $9.93M | $10.52M | 5.98% | 11/07/2024 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$0.57 | -$0.52 | -$0.58 | -11.54% | $9.11M | $9.59M | $9.48M | -1.18% | 08/07/2024 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$0.56 | -$0.42 | -$0.55 | -30.95% | $7.68M | $9.92M | $11.68M | 17.78% | 05/08/2024 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$1.16 | -$0.49 | -$0.33 | 32.65% | $10.53M | $8.90M | $14.03M | 57.62% | 03/07/2024 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$0.49 | -$0.51 | -$0.33 | 35.29% | $10.01M | $7.52M | $15.20M | 102.15% | 11/01/2023 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$0.52 | $0.41 | -$0.57 | -239.02% | $11.56M | $79.03M | $9.11M | -88.48% | 08/02/2023 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$0.56 | -$0.68 | -$0.56 | 17.65% | $9.29M | $7.43M | $7.68M | 3.41% | 05/03/2023 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$0.59 | -$0.61 | -$0.61 | 0.00% | $11.54M | $10.40M | $10.53M | 1.28% | 03/02/2023 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$0.58 | -$0.70 | -$0.49 | 30.00% | $9.06M | $10.64M | $10.01M | -5.90% | 11/02/2022 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$0.42 | -$0.52 | -$0.52 | 0.00% | $9.01M | $10.87M | $11.56M | 6.39% | 08/03/2022 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$0.50 | -$0.58 | -$0.56 | 3.45% | $7.32M | $9.89M | $9.29M | -6.03% | 05/04/2022 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$0.10 | -$0.53 | -$0.59 | -11.32% | $4.12M | $9.80M | $11.54M | 17.80% | 03/03/2022 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$0.30 | -$0.40 | -$0.58 | -45.00% | $7.49M | $9.84M | $9.06M | -7.94% | 11/03/2021 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$1.00 | -$0.43 | -$0.42 | 2.33% | $8.63M | $9.13M | $9.01M | -1.28% | 08/04/2021 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$1.10 | -$0.46 | -$0.50 | -8.70% | $2.51M | $7.93M | $7.32M | -7.65% | 05/05/2021 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$1.00 | -$0.17 | -$1.00 | -488.24% | $7.21M | $20.44M | $7.13M | -65.11% | 03/04/2021 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$1.50 | -$0.50 | -$0.30 | 40.00% | $2.01M | $10.54M | $15.70M | 48.91% | 11/05/2020 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$1.10 | -$1.00 | -$1.00 | 0.00% | $742.00K | $3.73M | $4.12M | 10.51% | 08/05/2020 | Get Alert |
| EYPT | EyePoint Pharmaceuticals | -$2.00 | -$1.00 | -$1.10 | -10.00% | $486.00K | $7.25M | $7.49M | 3.30% | 05/06/2020 | Get Alert |
EyePoint Pharmaceuticals (EYPT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-05 | $-0.64 | $-0.48 | -33.3 % |
| Q3 | 2024-11-07 | $-0.54 | $-0.55 | 1.82 % |
| Q2 | 2024-08-07 | $-0.58 | $-0.52 | -11.5 % |
| Q1 | 2024-05-08 | $-0.55 | $-0.42 | -30.9 % |
EyePoint Pharmaceuticals (EYPT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-05 | $11.59M | $11.02M | 5.15 % |
| Q3 | 2024-11-07 | $10.52M | $9.93M | 5.98 % |
| Q2 | 2024-08-07 | $9.48M | $9.59M | -1.18 % |
| Q1 | 2024-05-08 | $11.68M | $9.92M | 17.8 % |
FAQ
When is EyePoint Pharmaceuticals (NASDAQ:EYPT) reporting earnings?
EyePoint Pharmaceuticals (EYPT) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on March 5, 2025 for Q4.
What were the latest earnings per share (EPS) for EyePoint Pharmaceuticals (NASDAQ:EYPT)?
The Actual EPS was $-0.64, which missed the estimate of $-0.48.
What were EyePoint Pharmaceuticals’s (NASDAQ:EYPT) revenues?
The Actual Revenue was $11.6M, which beat the estimate of $11M.
Browse earnings estimates, EPS, and revenue on all stocks.